MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

NCT04895735 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Salivary Gland Carcinoma
Recurrent Salivary Gland Carcinoma
Stage IV Major Salivary Gland Cancer AJCC v8
Adenoid Cystic Carcinoma

Interventions

BIOLOGICAL: Pembrolizumab
DRUG: Pemetrexed Disodium
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: PSMA PET Scan

Sponsor

Mayo Clinic